Slovenia's Krka sees first-half group sales down by 3 pct

Krka dd Novo Mesto

18/06/2015 15:02

LJUBLJANA, June 18 (Reuters) - Slovenian generic drugs 
producer Krka  KRKG.LJ  expects group sales in the first half of 
the year to fall by 3 percent to some 580 million euros ($661 
million), due to lower sales in eastern and southeast Europe, 
the company said in a statement on Thursday. 
    It also said shareholders had confirmed a dividend of 2.2 
euros per share, up by 4.8 percent from last year.  
($1 = 0.8769 euros) 
 
 (Reporting by Marja Novak; Editing by David Holmes) 
 ((Marja.Novak@thomsonreuters.com; +386-1-5058805; Reuters 
Messaging: marja.novak.thomsonreuters.com@reuters.net)) 
 
Keywords: SLOVENIA KRKA/SALES